D54-20430-54604
3 vaccinations
5 coded responses
24 check-ins
5 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 770 / TX
- Registered
- 2021-01-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-13
Dose 1 — Moderna
-
2021-01-14
Registered in v-safe
- 2021-01-14
- 2021-01-16
- 2021-01-17
-
2021-01-18
Survey response — days 1–6 daily, dose 1MedDRA: Anxiety, Irritability — Feeling: Poor · Be unable to workFree text: Anxiety, irritabilityMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-18
- 2021-01-19
- 2021-01-22
- 2021-01-27
- 2021-02-03
-
2021-02-10
Dose 2 — Moderna
-
2021-02-11
Survey response — days 1–6 daily, dose 2MedDRA: Anxiety — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: AnxietyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-12
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-02-13
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-24
- 2021-03-03
- 2021-03-10
- 2021-03-17
- 2021-03-24
- 2021-05-12
-
2021-08-11
Survey response — 6 months, dose 2MedDRA: Conjunctivitis bacterial, Lower respiratory tract infection bacterial, Tympanic membrane perforation, Upper respiratory tract infection bacterial, Viral infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Viral then secondary bacterial Upper and lower respiratory infection; perforated ear drum; bacterial conjunctivitisMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-11
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-08-13
- 2021-08-18
- 2021-08-19
-
2021-08-20
Callback requested for11:00AM ET
-
2021-08-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2021-11-20
Dose 3 — Moderna
- 2022-02-10
-
2022-05-21
Survey response — 6 months, dose 3MedDRA: Pregnancy — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Pregnant. Due 7/18.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-21
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-05-23
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-11-20
Survey response — 12 months, dose 3MedDRA: Delivery, Hospitalisation, Pre-eclampsia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Had baby. diagnosed with. Postpartum pre eclampsia and readmitted.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-20
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2022-11-21
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Moderna | |
| 2 | 2021-02-10 | Moderna | |
| 3 | 2021-11-20 | Moderna | No |
Call center
4 call center cases
3 successful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Anxiety, irritability
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Anxiety
Release 9 — 6 months, dose 2
Symptoms: Viral then secondary bacterial Upper and lower respiratory infection; perforated ear drum; bacterial conjunctivitis
Release 11 — 6 months, dose 3
Symptoms: Pregnant. Due 7/18.
Release 12 — 12 months, dose 3
Symptoms: Had baby. diagnosed with. Postpartum pre eclampsia and readmitted.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Conjunctivitis bacterial | ✓ | · | ✓ |
| SD | Delivery | · | · | ✓ |
| SD | Hospitalisation | · | · | ✓ |
| SD | Lower respiratory tract infection bacterial | ✓ | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Tympanic membrane perforation | ✓ | · | ✓ |
| SD | Upper respiratory tract infection bacterial | ✓ | · | ✓ |
| SD | Viral infection | ✓ | · | ✓ |
| SRO | Anxiety | ✓ | ✓ | ✓ |
| SRO | Irritability | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release